Etanercept, adalimumab, and ustekinumab in psoriasis: analysis of 209 treatment series in Austria-Reference-Cited by-同舟云学术

Etanercept, adalimumab, and ustekinumab in psoriasis: analysis of 209 treatment series in Austria

Published:2017-02-27 Issue:3 Volume:15 Page:309-317
ISSN:1610-0379
Container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft
language:en
Short-container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft

Author:

Richter Leo¹,Vujic Igor¹²,Sesti Alma¹,Monshi Babak¹,Sanlorenzo Martina³,Posch Christian¹²,Rappersberger Klemens¹

Affiliation:

1. Rudolfstiftung Hospital; Department of Dermatology; Vienna Austria

2. School of Medicine; Sigmund Freud University Vienna; Austria

3. Department of Medical Sciences; Section of Dermatology; University of Turin; Italy

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ddg.13191/fullpdf

Reference42 articles.

1. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction;Stern;J Investig Dermatol Symp Proc,2004

2. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004;Kurd;J Am Acad Dermatol,2009

3. Severe psoriasis - oral therapy with a new retinoid;Fredriksson;Dermatologica,1978

4. Biological therapies in the systemic management of psoriasis: International Consensus Conference;Sterry;Br J Dermatol,2004

5. Retrospective data collection of psoriasis treatment with fumaric acid esters in children and adolescents in Germany (KIDS FUTURE study);Reich;J Dtsch Dermatol Ges,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durability and long-term outcomes of biologic therapies in psoriasis;Expert Review of Clinical Immunology;2023-08-25

2. Monitoring the effect of TNF-alpha inhibitors on laboratory parameters and adverse effects in different diseases: a retrospective, single-center study;Annals of Saudi Medicine;2022-09

3. Persistence With Biologic Treatments in Psoriasis: A Structured Literature Review of Studies Using Administrative Database and Clinical Registry Data;J DRUGS DERMATOL;2022

4. Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort;Acta Dermato-Venereologica;2022-05-16

5. Survival of biological therapeutics in psoriasis: Retrospective analysis of 3-years data in a Turkish Registry, PSORTAKSIS;TURKISH JOURNAL OF MEDICAL SCIENCES;2021